Viewpoint Series

Anti-VEGF treatment for neovascular age-related macular degeneration

Related articles:

Low risk to retina from sustained suppression of VEGF
Peter A. Campochiaro
Peter A. Campochiaro
Published June 24, 2019
Citation Information: J Clin Invest. 2019;129(8):3029-3031. https://doi.org/10.1172/JCI129861.
View: Text | PDF

Low risk to retina from sustained suppression of VEGF

Abstract

Authors

Peter A. Campochiaro

×
Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better
Ayumi Usui-Ouchi, Martin Friedlander
Ayumi Usui-Ouchi, Martin Friedlander
Published June 24, 2019
Citation Information: J Clin Invest. 2019;129(8):3032-3034. https://doi.org/10.1172/JCI129862.
View: Text | PDF